Suppr超能文献

两种莫里斯肝癌中微粒体甲基甾醇脱甲基酶的特性研究

Characterization of microsomal methyl sterol demethylase in two Morris hepatomas.

作者信息

Williams M T, Gaylor J L, Morris H P

出版信息

Cancer Res. 1976 Feb;36(2 Pt 1):291-7.

PMID:177191
Abstract

Previously, we reported that the rate of metabolism of methyl sterol intermediates of cholesterol biosynthesis by broken-cell preparations of Morriss hepatoma 7777 is very slow, whereas the intact tumors are known to synthesize cholesterol quite efficiently. Active preparations have now been obtained by substitution of pyrophosphate for phosphate buffer. Although substitution of pyrophosphate buffer markedly enhances microsomal methyl sterol demethylation rates 3- to 4-fold in hepatoma 7777, other microsomal enzymes and electron carriers in either liver or a more slowly growing hepatoma appear to be unaffected by pyrophosphate. Several properties of the active microsomal methyl sterol demethylase have now been compared for control rat liver, host liver, tumor 7777, and tumor 5123C. Conditions necessary for the assay of initial velocities of enzymic reactions in the tumor microsomes have been established with respect to the amount of protein, time-course, concentrations of cofactors and substrate, pH, and other variables. The K'm and the responses to the variables studied above are very similar for methyl sterol demethylase of microsomes isolated from control liver, host liver, tumor 5123C, and tumor 7777. The multienzymic demethylase in the various preparations has been found to be inhibited similarly by in vitro additions of cyanide, cytochrome c, and bile salts. Thus, the enzymes of the microsomal-bound 4-methyl sterol demethylase of cholesterol biosynthesis appear to be very similar in liver and these 2 Morris hepatomas. When xenobiotic inducers of microsomal oxidases, such as phenobarbital and methylcholanthrene, are administered to normal and tumor-bearing rats, elevated rates of methyl sterol demethylation are observed with isolated liver microsomes obtained from both normal and tumor-bearing rats. Similar increases are not observed in the tumors. Furthermore, daily administration of an intestinal bile acid sequestrant elevates hepatic methyl sterol demethylase, but statistically significant changes were not observed in tumors 7777 and 5123C. Since the enzymes of methyl sterol demethylase appear to be grossly similar in liver and these hepatomas, regulation of the activity of the multienzymic system contained in the tumors may be altered. On the other hand, these agents in vivo simply may not affect liver and the hepatomas similarly, due to a lack of uptake of the foreign substances by the tumor that has been transplanted to the thighs.

摘要

此前,我们报道过,莫里斯肝癌7777破碎细胞制剂对胆固醇生物合成中甲基甾醇中间体的代谢速率非常缓慢,而完整肿瘤已知能高效合成胆固醇。现在通过用焦磷酸盐替代磷酸盐缓冲液获得了活性制剂。尽管在肝癌7777中用焦磷酸盐缓冲液替代能使微粒体甲基甾醇脱甲基速率显著提高3至4倍,但肝脏或生长较慢的肝癌中的其他微粒体酶和电子载体似乎不受焦磷酸盐影响。现已比较了对照大鼠肝脏、宿主肝脏、肿瘤7777和肿瘤5123C中活性微粒体甲基甾醇脱甲基酶的若干特性。已就蛋白质含量、时间进程、辅因子和底物浓度、pH及其他变量确定了测定肿瘤微粒体中酶促反应初速度所需的条件。从对照肝脏、宿主肝脏、肿瘤5123C和肿瘤7777分离的微粒体中,甲基甾醇脱甲基酶的Km值以及对上述研究变量的反应非常相似。已发现各种制剂中的多酶脱甲基酶在体外添加氰化物、细胞色素c和胆汁盐时受到类似抑制。因此,肝脏和这两种莫里斯肝癌中微粒体结合的胆固醇生物合成4 - 甲基甾醇脱甲基酶的酶似乎非常相似。当给正常和荷瘤大鼠施用微粒体氧化酶的外源性诱导剂,如苯巴比妥和甲基胆蒽时,从正常和荷瘤大鼠分离的肝脏微粒体中观察到甲基甾醇脱甲基速率升高。在肿瘤中未观察到类似增加。此外,每日施用肠道胆汁酸螯合剂可提高肝脏甲基甾醇脱甲基酶,但在肿瘤7777和5123C中未观察到统计学上的显著变化。由于甲基甾醇脱甲基酶的酶在肝脏和这些肝癌中似乎大致相似,肿瘤中所含多酶系统活性的调节可能发生了改变。另一方面,由于移植到大腿的肿瘤对外源物质缺乏摄取,这些体内物质可能根本不会以类似方式影响肝脏和肝癌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验